Statistics for Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction
Total visits
views | |
---|---|
Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction | 130 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
khvi-15-7-8-1564438.pdf | 193 |
java.util.UUID:de5d0112-6781-4d61-833d-6bf595176ba8 | 95 |
java.util.UUID:ebc1882e-ab16-4615-b518-3336c464204a | 17 |
java.util.UUID:08d5af5e-d2c3-474a-b504-2ab8f6ee5180 | 4 |
Top country views
views | |
---|---|
United States | 103 |
Germany | 3 |
Canada | 2 |
China | 2 |
Sweden | 2 |
Ukraine | 2 |
France | 1 |
United Kingdom | 1 |
Malaysia | 1 |
Vietnam | 1 |
Top city views
views | |
---|---|
Wilmington | 45 |
Fairfield | 13 |
Houston | 13 |
Cambridge | 7 |
Jacksonville | 4 |
Kiez | 3 |
San Francisco | 3 |
Kiev | 2 |
Shenzhen | 2 |
Stockholm | 2 |
Toronto | 2 |
Ann Arbor | 1 |
Chicago | 1 |
Dallas | 1 |
Dong Ket | 1 |
Paris | 1 |
Seattle | 1 |
Seremban | 1 |